Global Biopharmaceutical Cro Market Size & Outlook
Global biopharmaceutical cro market, 2021-2033 (US$M)
Related Markets
Global biopharmaceutical cro market highlights
- The global biopharmaceutical cro market generated a revenue of USD 28,467.3 million in 2024 and is expected to reach USD 59,628.8 million by 2033.
- The market is expected to grow at a CAGR (2025 - 2033) of 8.7% by 2033.
- In terms of segment, clinical accounted for a revenue of USD 23,102.5 million in 2024.
- Pre-Clinical is the most lucrative type segment registering the fastest growth during the forecast period.
- In terms of region, Asia Pacific was the largest revenue generating market in 2024.
- Country-wise, China is expected to register the highest CAGR from 2025 to 2033.
Global data book summary
| Market revenue in 2024 | USD 28,467.3 million |
| Market revenue in 2033 | USD 59,628.8 million |
| Growth rate | 8.7% (CAGR from 2025 to 2033) |
| Largest segment | Clinical |
| Fastest growing segment | Pre-Clinical |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Drug Discovery, Pre-Clinical, Clinical |
Other key industry trends
- In terms of revenue, the North America accounted for 22.4% of the global biopharmaceutical cro market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
- By country, China is the fastest growing regional market and is projected to reach USD 9,785.9 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biopharmaceutical CRO Market Scope
Biopharmaceutical CRO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Medpace | View profile | - | - | - |
| Clinipace | View profile | - | - | - |
| LabCorp | View profile | - | - | - |
| WuXi AppTec | View profile | - | - | - |
| Fortrea Holdings Inc | View profile | 16000 | 8 Moore Drive, Durham, NC, United States, 27709 | https://www.fortrea.com |
| IQVIA | View profile | 10001+ | Danbury, Connecticut, United States, North America | https://www.iqvia.com |
| Worldwide Clinical Trials | View profile | 1001-5000 | Morrisville, North Carolina, United States, North America | https://www.worldwide.com |
| Syneos Health | View profile | 1001-5000 | Morrisville, North Carolina, United States, North America | https://www.syneoshealth.com/ |
| PAREXEL | View profile | 10001+ | Waltham, Massachusetts, United States, North America | http://www.parexel.com |
| Catalent Inc | View profile | 17219 | 14 Schoolhouse Road, Somerset, NJ, United States, 08873 | https://www.catalent.com |
| Icon PLC | View profile | 41150 | South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 | https://www.iconplc.com |
| Charles River Laboratories International Inc | View profile | 21400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | https://www.criver.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Lonza Group Ltd | View profile | 18000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | https://www.lonza.com |
Global biopharmaceutical cro market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharmaceutical cro market will help companies and investors design strategic landscapes.
Clinical was the largest segment with a revenue share of 81.15% in 2024. Horizon Databook has segmented the Global biopharmaceutical cro market based on drug discovery, pre-clinical, clinical covering the revenue growth of each sub-segment from 2021 to 2033.
- Global Biopharmaceutical CRO Type Outlook (Revenue, USD Million, 2021-2033)
- Drug Discovery
- Target Validation
- Lead Identification
- Lead Optimization
- Pre-Clinical
- Clinical
- Phase I Trial Services
- Phase II Trial Services
- Phase III Trial Services
- Phase IV Trial Services
- Drug Discovery
- Global Biopharmaceutical CRO Product Outlook (Revenue, USD Million, 2021-2033)
- Monoclonal antibodies (mAbs)
- Recombinant proteins & enzymes
- Vaccines
- Cell & Gene Therapies
- Nucleic acid Therapeutics
- Others
- Global Biopharmaceutical CRO Service Outlook (Revenue, USD Million, 2021-2033)
- Project Management/Clinical Supply Management
- Data Management
- Regulatory/Medical Affairs
- Medical Writing
- Clinical Monitoring
- Quality Management/ Assurance
- Bio-statistics
- Investigator Payments
- Laboratory
- Patient And Site Recruitment
- Technology
- Others
- Global Biopharmaceutical CRO Therapeutic Area Outlook (Revenue, USD Million, 2021-2033)
- Oncology
- CNS Disorders
- Infectious Diseases
- Immunological Disorders
- Cardiovascular Disease
- Respiratory Diseases
- Diabetes
- Ophthalmology
- Pain Management
- Others
- Global Biopharmaceutical CRO End Use Outlook (Revenue, USD Million, 2021-2033)
- Large Pharmaceutical & Biotechnology companies
- Small & Mid-Size Sponsors
- Academic & Government research
Reasons to subscribe to Global biopharmaceutical cro market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global biopharmaceutical cro market databook
-
Our clientele includes a mix of biopharmaceutical cro market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global biopharmaceutical cro market , including forecasts for subscribers. This global databook contains high-level insights into Global biopharmaceutical cro market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global biopharmaceutical cro market size, by regions, 2021-2033 (US$M)
Top 10 countries: Biopharmaceutical cro market size, 2024 (US$M)
Global biopharmaceutical cro market share, by type, 2024 & 2033 (%, US$M)
Biopharmaceutical cro market: Opportunity assessment by country
Global biopharmaceutical cro market, by region, 2024 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
